Updates in the Management of Diffuse Large B-Cell LymphomaByYazan Samhouri, MDJune 21st 2023Yazan Samhouri, MD, discusses the latest advancements in the diffuse large B-cell lymphoma treatment landscape.
Significance of the TRIANGLE Study of Frontline Ibrutinib for MCLByYazan Samhouri, MDJanuary 31st 2023Yazan Samhouri, MD, discusses his impressions of the TRIANGLE clinical trial presented at the 2022 American Society of Hematology Annual Meeting.